Skip to main content
PMC home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1990 Nov;87(21):8660–8664. doi: 10.1073/pnas.87.21.8660

Correlation of the structure of the transmembrane domain of the neu oncogene-encoded p185 protein with its function.

P W Brandt-Rauf 1, S Rackovsky 1, M R Pincus 1
PMCID: PMC55017  PMID: 1978329

Abstract

The human homologue of the neu oncogene is frequently found in human tumors. Certain amino acid substitutions at position 664 in the transmembrane domain of the neu oncogene-encoded p185 protein product are known to cause malignant transformation of cells. Using conformational energy analysis based on ECEPP (empirical conformational energies for polypeptides program), we have previously determined the preferred three-dimensional structures for the transmembrane domain of the p185 protein with a transforming (glutamic acid) and a nontransforming (valine) substitution at the critical position 664 and found that the global minimum-energy conformation of this region in the nontransforming protein contains a sharp bend, whereas the global minimum-energy conformation for this region from the transforming protein is entirely alpha-helical. We now demonstrate that this result holds for other known nontransforming (glycine, histidine, tyrosine, and lysine) and transforming (glutamine) substitutions at position 664. Furthermore, a simple statistical thermodynamic analysis of the results indicates that approximately 85% of each of the nontransforming sequences exist with the bend at positions 664 and 665, while approximately 90% of each of the transforming sequences exist as an alpha-helix. About 9% of the nontransforming sequences exist as the alpha-helix. These results suggest that if the intracellular concentration of the normal protein is increased at least 10-fold, thereby increasing the alpha-helical form by this factor, cell transformation should result. This conclusion is directly supported by genetic experiments in which this level of overexpression of the normal protein was achieved with attendant cell transformation.

Full text

PDF
8660

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bargmann C. I., Hung M. C., Weinberg R. A. Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185. Cell. 1986 Jun 6;45(5):649–657. doi: 10.1016/0092-8674(86)90779-8. [DOI] [PubMed] [Google Scholar]
  2. Bargmann C. I., Hung M. C., Weinberg R. A. The neu oncogene encodes an epidermal growth factor receptor-related protein. Nature. 1986 Jan 16;319(6050):226–230. doi: 10.1038/319226a0. [DOI] [PubMed] [Google Scholar]
  3. Bargmann C. I., Weinberg R. A. Oncogenic activation of the neu-encoded receptor protein by point mutation and deletion. EMBO J. 1988 Jul;7(7):2043–2052. doi: 10.1002/j.1460-2075.1988.tb03044.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brandt-Rauf P. W., Carty R. P., Chen J., Avitable M., Lubowsky J., Pincus M. R. Structure of the carboxyl terminus of the RAS gene-encoded P21 proteins. Proc Natl Acad Sci U S A. 1988 Aug;85(16):5869–5873. doi: 10.1073/pnas.85.16.5869. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brandt-Rauf P. W., Pincus M. R., Chen J. M. Conformational changes induced by the transforming amino acid substitution in the transmembrane domain of the neu oncogene-encoded p185 protein. J Protein Chem. 1989 Dec;8(6):749–756. doi: 10.1007/BF01024899. [DOI] [PubMed] [Google Scholar]
  6. Brandt-Rauf P. W., Pincus M. R., Chen J. M., Lee G. Conformational energy analysis of the leucine repeat regions of C/EBP, GCN4, and the proteins of the myc, jun, and fos oncogenes. J Protein Chem. 1989 Oct;8(5):679–688. doi: 10.1007/BF01025608. [DOI] [PubMed] [Google Scholar]
  7. Chen J. M., Lee G., Murphy R. B., Carty R. P., Brandt-Rauf P. W., Friedman E., Pincus M. R. Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form. J Biomol Struct Dyn. 1989 Apr;6(5):859–875. doi: 10.1080/07391102.1989.10506518. [DOI] [PubMed] [Google Scholar]
  8. Di Fiore P. P., Pierce J. H., Kraus M. H., Segatto O., King C. R., Aaronson S. A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987 Jul 10;237(4811):178–182. doi: 10.1126/science.2885917. [DOI] [PubMed] [Google Scholar]
  9. Dygert M., Gō N., Scheraga H. A. Use of a symmetry condition to compute the conformation of gramicidin S1. Macromolecules. 1975 Nov-Dec;8(6):750–761. doi: 10.1021/ma60048a016. [DOI] [PubMed] [Google Scholar]
  10. Fukushige S., Matsubara K., Yoshida M., Sasaki M., Suzuki T., Semba K., Toyoshima K., Yamamoto T. Localization of a novel v-erbB-related gene, c-erbB-2, on human chromosome 17 and its amplification in a gastric cancer cell line. Mol Cell Biol. 1986 Mar;6(3):955–958. doi: 10.1128/mcb.6.3.955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hudziak R. M., Schlessinger J., Ullrich A. Increased expression of the putative growth factor receptor p185HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987 Oct;84(20):7159–7163. doi: 10.1073/pnas.84.20.7159. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. King C. R., Kraus M. H., Aaronson S. A. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science. 1985 Sep 6;229(4717):974–976. doi: 10.1126/science.2992089. [DOI] [PubMed] [Google Scholar]
  13. Padhy L. C., Shih C., Cowing D., Finkelstein R., Weinberg R. A. Identification of a phosphoprotein specifically induced by the transforming DNA of rat neuroblastomas. Cell. 1982 Apr;28(4):865–871. doi: 10.1016/0092-8674(82)90065-4. [DOI] [PubMed] [Google Scholar]
  14. Pincus M. R., Brandt-Rauf P. W., Carty R. P., Lubowsky J., Avitable M., Gibson K. D., Scheraga H. A. Conformational effects of substituting amino acids for glutamine-61 on the central transforming region of the P21 proteins. Proc Natl Acad Sci U S A. 1987 Dec;84(23):8375–8379. doi: 10.1073/pnas.84.23.8375. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Pincus M. R., Brandt-Rauf P. W. Structural effects of substitutions on the p21 proteins. Proc Natl Acad Sci U S A. 1985 Jun;82(11):3596–3600. doi: 10.1073/pnas.82.11.3596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Pincus M. R., Klausner R. D. Prediction of the three-dimensional structure of the leader sequence of pre-kappa light chain, a hexadecapeptide. Proc Natl Acad Sci U S A. 1982 Jun;79(11):3413–3417. doi: 10.1073/pnas.79.11.3413. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Pincus M. R., Klausner R. D., Scheraga H. A. Calculation of the three-dimensional structure of the membrane-bound portion of melittin from its amino acid sequence. Proc Natl Acad Sci U S A. 1982 Aug;79(16):5107–5110. doi: 10.1073/pnas.79.16.5107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Pincus M. R., van Renswoude J., Harford J. B., Chang E. H., Carty R. P., Klausner R. D. Prediction of the three-dimensional structure of the transforming region of the EJ/T24 human bladder oncogene product and its normal cellular homologue. Proc Natl Acad Sci U S A. 1983 Sep;80(17):5253–5257. doi: 10.1073/pnas.80.17.5253. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Ponnuswamy P. K., Warme P. K., Scheraga H. A. Role of medium-range interactions in proteins. Proc Natl Acad Sci U S A. 1973 Mar;70(3):830–833. doi: 10.1073/pnas.70.3.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Semba K., Kamata N., Toyoshima K., Yamamoto T. A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma. Proc Natl Acad Sci U S A. 1985 Oct;82(19):6497–6501. doi: 10.1073/pnas.82.19.6497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Shah D., Chen J. M., Carty R. P., Pincus M. R., Scheraga H. A. Correlation of beta-bend conformations of tetrapeptides with their activities in CD4-receptor binding assays. Int J Pept Protein Res. 1989 Oct;34(4):325–332. doi: 10.1111/j.1399-3011.1989.tb01582.x. [DOI] [PubMed] [Google Scholar]
  22. Shih C., Padhy L. C., Murray M., Weinberg R. A. Transforming genes of carcinomas and neuroblastomas introduced into mouse fibroblasts. Nature. 1981 Mar 19;290(5803):261–264. doi: 10.1038/290261a0. [DOI] [PubMed] [Google Scholar]
  23. Slamon D. J., Clark G. M., Wong S. G., Levin W. J., Ullrich A., McGuire W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987 Jan 9;235(4785):177–182. doi: 10.1126/science.3798106. [DOI] [PubMed] [Google Scholar]
  24. Stern D. F., Heffernan P. A., Weinberg R. A. p185, a product of the neu proto-oncogene, is a receptorlike protein associated with tyrosine kinase activity. Mol Cell Biol. 1986 May;6(5):1729–1740. doi: 10.1128/mcb.6.5.1729. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sternberg M. J., Gullick W. J. Neu receptor dimerization. Nature. 1989 Jun 22;339(6226):587–587. doi: 10.1038/339587a0. [DOI] [PubMed] [Google Scholar]
  26. Weiner D. B., Liu J., Cohen J. A., Williams W. V., Greene M. I. A point mutation in the neu oncogene mimics ligand induction of receptor aggregation. Nature. 1989 May 18;339(6221):230–231. doi: 10.1038/339230a0. [DOI] [PubMed] [Google Scholar]
  27. Yarden Y. Agonistic antibodies stimulate the kinase encoded by the neu protooncogene in living cells but the oncogenic mutant is constitutively active. Proc Natl Acad Sci U S A. 1990 Apr;87(7):2569–2573. doi: 10.1073/pnas.87.7.2569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Yokota J., Yamamoto T., Toyoshima K., Terada M., Sugimura T., Battifora H., Cline M. J. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo. Lancet. 1986 Apr 5;1(8484):765–767. doi: 10.1016/s0140-6736(86)91782-4. [DOI] [PubMed] [Google Scholar]
  29. Zimmerman S. S., Pottle M. S., Némethy G., Scheraga H. A. Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP. Macromolecules. 1977 Jan-Feb;10(1):1–9. doi: 10.1021/ma60055a001. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES